BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 26671523)

  • 41. Pharmacists' knowledge and interest in developing counseling skills relating to oral contraceptives.
    Amin ME
    Int J Clin Pharm; 2016 Apr; 38(2):395-403. PubMed ID: 26873480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada.
    Abbott R; Edwards S; Whelan M; Edwards J; Dranitsaris G
    J Oncol Pharm Pract; 2014 Feb; 20(1):29-39. PubMed ID: 24103897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronotherapy in practice: the perspective of the community pharmacist.
    Kaur G; Gan YL; Phillips CL; Wong K; Saini B
    Int J Clin Pharm; 2016 Feb; 38(1):171-82. PubMed ID: 26644017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community pharmacists' views of using a screening tool to structure medicines use reviews for older people: findings from qualitative interviews.
    Cardwell K; Hughes CM; Ryan C
    Int J Clin Pharm; 2018 Oct; 40(5):1086-1095. PubMed ID: 29796962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What Do Breastfeeding Women Taking Herbal Galactagogues Perceive of Community Pharmacists' Role in Breastfeeding Support? A Qualitative Study.
    Sim TF; Hattingh HL; Sherriff J; Tee LB
    Int J Environ Res Public Health; 2015 Sep; 12(9):11132-45. PubMed ID: 26371023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies.
    McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J
    BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community pharmacists' attitudes and opinions towards supplying clozapine.
    Gan YL; O'Reilly CL
    Int J Clin Pharm; 2018 Oct; 40(5):1116-1130. PubMed ID: 29936642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a pharmacist-led, medicines education program for Aboriginal Health Workers.
    McRae M; Taylor SJ; Swain L; Sheldrake C
    Rural Remote Health; 2008; 8(4):946. PubMed ID: 19093711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
    Almansour HA; Chaar B; Saini B
    Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.
    Kinsey H; Scahill S; Bye L; Harrison J
    Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study.
    Hashmi F; Hassali MA; Saleem F; Saeed H; Islam M; Malik UR; Atif N; Babar ZU
    Int J Clin Pharm; 2021 Aug; 43(4):1090-1100. PubMed ID: 33411180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs.
    Blake KB; Madhavan SS; Scott VG; Meredith Elswick BL
    Res Social Adm Pharm; 2009 Jun; 5(2):182-8. PubMed ID: 19524865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community pharmacists' experiences in mental illness and addictions care: a qualitative study.
    Murphy AL; Phelan H; Haslam S; Martin-Misener R; Kutcher SP; Gardner DM
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():6. PubMed ID: 26821700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.